Infectious Disease Diagnostics Market will grow at 8.5% CAGR, to be valued at US$ 1,841.2 Million by 2027 – Coherent Market Insights

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Global Infectious Disease Diagnostics Market

Infectious diseases are caused by organisms like bacteria, viruses, fungi, and parasites and are capable of transmission from one species to another species. Diagnosis of these diseases involves identifying the pathogen and its type and the degree up to which the infection has spread. Infectious diseases such as HIV, tuberculosis, malaria, and Influenza are highly prevalent and can be efficiently diagnosed with the help of diagnostic tests available for the respective diseases.

Get Sample PDF Brochure with Impact of COVID19: https://www.coherentmarketinsights.com/insight/request-sample/1971

Technologies utilized by these diagnostic tests are generally classified as biochemical techniques, molecular techniques, immunodiagnostics, and conventional culturing, and staining techniques. The biochemical techniques include ELISA, agglutination, and others, whereas, the molecular techniques include Polymerase Chain Reaction (PCR) and Next-Generation Sequencing techniques. These tests are capable of diagnosing the infectious diseases accurately with high throughput capacity.

Advances in molecular testing techniques have resulted in fast diagnosis of infectious diseases in real-time due to which patients can receive treatment early. Commercially available diagnostic tests include BD Max Smart Cycler, GeneXpert, BD Phoenix CPO detect test, Xpert Xpress Strep A, and BioPlex 2200 Syphilis Total & RPR Assay.

Growing prevalence of various infectious diseases to boost the market growth over the projected period

Infectious diseases such as HIV, tuberculosis, and malaria are prevalent in emerging economies such as Africa and Asia Pacific. For instance, according to the World Health Organization (WHO), an estimated 36.7 million people were suffering from HIV in 2016.

Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!

Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/1971

According to the World Health Organization (WHO), in 2015, an estimated 32,000 deaths from tuberculosis and around 323,000 new cases of TB cases were registered in the Europe. Moreover, around 323,000 incident of TB cases in this region includes 27,000 cases with HIV co-infection. The data published in the Journal of Infection and Public Health suggested that infectious diseases reported the significant causes of deaths in Brazil, in 2016. The high concentration of burden rates observed among men, children under 5 years of age at the coast regions of the state.

The Centers for Disease Control and Prevention (CDC) reported that around 5,251 deaths were reported due to influenza infection were registered in 2015. Furthermore, as per the National Ambulatory Medical Care Survey: 2015 data findings, around 16.8 million people visit to physician for treatment of infectious and parasitic diseases in the U.S.

The global infectious disease diagnostics market was assessed at US$ 1,131.4 Mn in 2020, and is expected to witness a robust CAGR of 8.5% over the forecast period (2020-2027).

Partnerships and collaborations by market players to develop novel diagnostic techniques

Individual organizations, manufacturers, and research institutes are forming partnerships, and collaborations to advance research and development of diagnostic tests for infectious diseases. Moreover, funding by individual organizations to advance research is expected to boost the growth of the market over the forecast period. For instance, the University of Virginia’s Global Infectious Diseases Institute funded seven projects designed to tackle challenging problems in infectious diseases worldwide in July 2018. They have formed collaborative teams across diverse academic disciplines to control and treat Zika virus infections and to reduce tuberculosis rates among HIV-infected patients in Africa.

The New York Governor’s Office announced a research collaboration with Regeneron Pharmaceuticals, Inc. to advance the diagnosis and treatment of tick-borne diseases in June 2018. Moreover, Infectious Diseases Society of America (IDSA) and American Society for Microbiology (ASM) released a guide in July 2018, which is expected to help healthcare providers to understand latest technology trends, and knowledge on when to order which test. These factors are expected to affect the growth of infectious disease diagnostic market over the forecast period.

However, underdeveloped centralized laboratory facilities in emerging economies, such as the Middle East and Africa, are expected to hinder the growth of the global market over the forecast timeline. Lack of awareness in healthcare professionals, as well as patients towards innovative diagnostic solutions, is expected to restrain the infectious disease diagnostics market growth.

View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/infectious-disease-diagnostics-market-to-surpass-us-257-billion-threshold-by-2026-globally-1033

Global Infectious Disease Diagnostics Market: Competitive Landscape

Major players operating in the global infectious disease diagnostics market include Becton Dickinson & Company, Cepheid, Inc., Abbott Laboratories, BioMerieux SA, Hologic, Inc., Danaher Corporation, Thermo Fisher Scientific, Inc., Roche Diagnostics, DiaSorin S.p.A., Quidel Corporation, and Bio-Rad Laboratories, Inc.

Detailed Segmentation

• Global Infectious Disease Diagnostics Market, By Technique:
  • ELISA
  • Polymerase Chain Reaction
  • Immunoassays
  • Cell Cultures
  • Others
• Global Infectious Disease Diagnostics Market, By Disease Indication:
  • CNS Infection
    • Meningitis
    • Brain Abscess
  • Diarrheal Disease
    • Shigellosis
    • Cholera
    • Enteric/Typhoid Fever
  • Respiratory Infections
    • Tuberculosis
    • Influenza
    • Bronchitis
  • Blood Infections
    • Malaria
    • Dengue
    • Infectious Mononucleosis
    • Others
  • STDs
    • Chlamydia
    • AIDS
    • Syphilis
    • Others
• Global Infectious Disease Diagnostics Market, By End User:
  • Hospitals
  • Diagnostic Centers
  • Clinics
  • Government Organizations

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at contact@cdnnewswire.com.